CBLN3
gene geneOn this page
Summary
CBLN3 (cerebellin 3 precursor, HGNC:20146) is a protein-coding gene on chromosome 14q12, encoding Cerebellin-3 (Q6UW01). May be involved in synaptic functions in the CNS.
Members of the precerebellin family, such as CBLN3, contain a cerebellin motif (see CBLN1; MIM 600432) and a C-terminal C1q signature domain (see MIM 120550) that mediates trimeric assembly of atypical collagen complexes. However, precerebellins do not contain a collagen motif, suggesting that they are not conventional components of the extracellular matrix (Pang et al., 2000 [PubMed 10964938]).
Source: NCBI Gene 643866 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 44 total
- MANE Select transcript:
NM_001039771
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20146 |
| Approved symbol | CBLN3 |
| Name | cerebellin 3 precursor |
| Location | 14q12 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000139899 |
| Ensembl biotype | protein_coding |
| OMIM | 612978 |
| Entrez | 643866 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000267406, ENST00000555436, ENST00000859360, ENST00000859361
RefSeq mRNA: 1 — MANE Select: NM_001039771
NM_001039771
CCDS: CCDS32057
Canonical transcript exons
ENST00000267406 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000940676 | 24428755 | 24429668 |
| ENSE00000940677 | 24428286 | 24428405 |
| ENSE00000940678 | 24426545 | 24427986 |
Expression profiles
Bgee: expression breadth ubiquitous, 166 present calls, max score 98.92.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3957 / max 32.6245, expressed in 160 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 142604 | 0.3957 | 160 |
Top tissues by expression
243 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cerebellar vermis | UBERON:0004720 | 98.92 | gold quality |
| cerebellum | UBERON:0002037 | 98.33 | gold quality |
| cerebellar cortex | UBERON:0002129 | 98.31 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 98.26 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 97.50 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 90.81 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 87.48 | gold quality |
| right adrenal gland | UBERON:0001233 | 86.34 | gold quality |
| pons | UBERON:0000988 | 86.18 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 84.06 | gold quality |
| left adrenal gland | UBERON:0001234 | 83.70 | gold quality |
| adrenal cortex | UBERON:0001235 | 83.22 | gold quality |
| adrenal gland | UBERON:0002369 | 81.52 | gold quality |
| lymph node | UBERON:0000029 | 80.98 | gold quality |
| ileal mucosa | UBERON:0000331 | 79.27 | silver quality |
| spleen | UBERON:0002106 | 79.06 | gold quality |
| left ovary | UBERON:0002119 | 78.23 | gold quality |
| vermiform appendix | UBERON:0001154 | 78.03 | gold quality |
| tibialis anterior | UBERON:0001385 | 77.89 | silver quality |
| right ovary | UBERON:0002118 | 77.66 | gold quality |
| adrenal tissue | UBERON:0018303 | 77.01 | gold quality |
| right coronary artery | UBERON:0001625 | 76.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 76.28 | gold quality |
| omental fat pad | UBERON:0010414 | 76.28 | gold quality |
| peritoneum | UBERON:0002358 | 76.22 | gold quality |
| adult organism | UBERON:0007023 | 76.17 | gold quality |
| left coronary artery | UBERON:0001626 | 75.61 | gold quality |
| apex of heart | UBERON:0002098 | 75.57 | gold quality |
| gall bladder | UBERON:0002110 | 75.00 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 74.98 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.04 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
79 targeting CBLN3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-3912-5P | 99.95 | 66.11 | 925 |
| HSA-MIR-380-3P | 99.89 | 70.18 | 1978 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-609 | 99.82 | 64.26 | 505 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-636 | 99.80 | 69.58 | 1500 |
| HSA-MIR-11181-3P | 99.75 | 66.38 | 2205 |
| HSA-MIR-92A-2-5P | 99.75 | 67.01 | 2164 |
| HSA-MIR-6745 | 99.74 | 65.33 | 1321 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-1296-3P | 99.72 | 64.04 | 636 |
| HSA-MIR-518A-5P | 99.70 | 69.01 | 2209 |
| HSA-MIR-527 | 99.70 | 69.01 | 2209 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-6766-5P | 99.68 | 67.70 | 2325 |
| HSA-MIR-6134 | 99.63 | 65.68 | 1537 |
| HSA-MIR-298 | 99.63 | 67.56 | 1916 |
Cross-species orthologs
18 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cbln8 | ENSDARG00000019294 |
| danio_rerio | cbln10 | ENSDARG00000023157 |
| danio_rerio | cbln13 | ENSDARG00000026904 |
| danio_rerio | cbln9 | ENSDARG00000030254 |
| danio_rerio | cbln6 | ENSDARG00000035718 |
| danio_rerio | cbln5 | ENSDARG00000053802 |
| danio_rerio | cbln14 | ENSDARG00000053845 |
| danio_rerio | cbln12 | ENSDARG00000068232 |
| danio_rerio | cbln11 | ENSDARG00000086654 |
| danio_rerio | cbln20 | ENSDARG00000087476 |
| danio_rerio | si:ch211-142d6.2 | ENSDARG00000088625 |
| danio_rerio | cbln17 | ENSDARG00000088911 |
| danio_rerio | cbln18 | ENSDARG00000090969 |
| danio_rerio | cbln7 | ENSDARG00000095040 |
| danio_rerio | si:dkeyp-110c7.4 | ENSDARG00000100476 |
| danio_rerio | si:dkeyp-74b6.2 | ENSDARG00000115070 |
| mus_musculus | Cbln3 | ENSMUSG00000040380 |
| rattus_norvegicus | Cbln3 | ENSRNOG00000020503 |
Paralogs (3): CBLN4 (ENSG00000054803), CBLN1 (ENSG00000102924), CBLN2 (ENSG00000141668)
Protein
Protein identifiers
Cerebellin-3 — Q6UW01 (reviewed: Q6UW01)
All UniProt accessions (2): Q6UW01, G3V2Y8
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in synaptic functions in the CNS.
Subunit / interactions. Heterohexamer; disulfide-linked heterotrimers. Interacts with CBLN1. May also form oligomers with CBLN2 and CBLN4.
Subcellular location. Endoplasmic reticulum. Golgi apparatus. cis-Golgi network. Secreted. Synapse.
RefSeq proteins (1): NP_001034860* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001073 | C1q_dom | Domain |
| IPR008983 | Tumour_necrosis_fac-like_dom | Homologous_superfamily |
| IPR050822 | Cerebellin_Synaptic_Org | Family |
Pfam: PF00386
UniProt features (7 total): disulfide bond 2, signal peptide 1, chain 1, domain 1, region of interest 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6UW01-F1 | 77.67 | 0.50 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (2): 45, 49
Glycosylation sites (1): 90
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 74 (showing top):
GOBP_CELLULAR_COMPONENT_MAINTENANCE, chr14q12, GOBP_CELL_CELL_SIGNALING, GOBP_CELL_JUNCTION_ORGANIZATION, GOBP_SYNAPTIC_SIGNALING, IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR, GOCC_EXCITATORY_SYNAPSE, LEIN_CEREBELLUM_MARKERS, GOCC_SYNAPSE, MARSON_BOUND_BY_FOXP3_STIMULATED, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, MIKKELSEN_ES_ICP_WITH_H3K4ME3, MIKKELSEN_NPC_ICP_WITH_H3K4ME3, GOBP_SYNAPSE_ORGANIZATION, GOBP_CELL_JUNCTION_MAINTENANCE
GO Biological Process (1): maintenance of synapse structure (GO:0099558)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (7): obsolete extracellular space (GO:0005615), endoplasmic reticulum (GO:0005783), Golgi apparatus (GO:0005794), synaptic cleft (GO:0043083), synapse (GO:0045202), parallel fiber to Purkinje cell synapse (GO:0098688), extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 2 |
| endomembrane system | 2 |
| intracellular membrane-bounded organelle | 2 |
| cellular anatomical structure | 2 |
| cell junction maintenance | 1 |
| synapse organization | 1 |
| binding | 1 |
| extracellular region | 1 |
| cell junction | 1 |
| excitatory synapse | 1 |
Protein interactions and networks
STRING
808 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CBLN3 | GRID2 | O43424 | 861 |
| CBLN3 | TMEM69 | Q5SWH9 | 581 |
| CBLN3 | CCDC137 | Q6PK04 | 573 |
| CBLN3 | NYNRIN | Q9P2P1 | 558 |
| CBLN3 | CLEC19A | Q6UXS0 | 555 |
| CBLN3 | ZC3H10 | Q96K80 | 533 |
| CBLN3 | STXBP6 | Q8NFX7 | 524 |
| CBLN3 | STOML1 | Q9UBI4 | 514 |
| CBLN3 | SDR39U1 | Q9NRG7 | 511 |
| CBLN3 | PECR | Q9BY49 | 460 |
| CBLN3 | CBLN2 | Q8IUK8 | 455 |
| CBLN3 | LAMB4 | A4D0S4 | 440 |
| CBLN3 | BEAN1 | Q3B7T3 | 432 |
| CBLN3 | RNF17 | Q9BXT8 | 408 |
| CBLN3 | FAT2 | Q9NYQ8 | 407 |
| CBLN3 | CYP4V2 | Q6ZWL3 | 407 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: D4AB34, O54907, O55237, O75888, O77510, O95150, P01374, P01375, P04924, P09225, P10154, P19101, P26445, P29553, P32970, P33620, P41273, P48094, P51435, P59695, P61125, P63307, P79337, P98087, Q06332, Q06600, Q17QF9, Q19LH4, Q1WM27, Q3ZDR4, Q5TM20, Q5UBV8, Q5WR07, Q6PGN1, Q6UW01, Q75N23, Q861W5, Q8BGU2, Q8HZD9, Q8IUK8
Diamond homologs: A0A060WQA3, A5PN28, A6NHN0, B2RNN3, O75973, O88992, P02745, P02746, P02747, P08125, P0C862, P14282, P23206, P23435, P25067, P25318, P27658, P31720, P63182, P83371, P86437, P98085, P98086, P98087, Q00780, Q02105, Q03692, Q05306, Q05A80, Q0II24, Q15848, Q17QF9, Q2KIV9, Q3Y5Z3, Q4ZJM7, Q4ZJM9, Q4ZJN1, Q5E9E3, Q5FVH0, Q5RJ80
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
44 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 42 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
804 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:24428284:AC:A | donor_loss | 1.0000 |
| 14:24428285:C:G | donor_loss | 1.0000 |
| 14:24428307:CACCT:C | donor_gain | 1.0000 |
| 14:24430927:CCAAG:C | donor_loss | 1.0000 |
| 14:24430928:CAAG:C | donor_loss | 1.0000 |
| 14:24430929:AAGG:A | donor_loss | 1.0000 |
| 14:24430930:AGGT:A | donor_loss | 1.0000 |
| 14:24430931:GGTGA:G | donor_loss | 1.0000 |
| 14:24430932:G:GA | donor_loss | 1.0000 |
| 14:24430933:T:G | donor_loss | 1.0000 |
| 14:24427983:TCACC:T | acceptor_loss | 0.9900 |
| 14:24427986:CCT:C | acceptor_loss | 0.9900 |
| 14:24427987:CTGGG:C | acceptor_loss | 0.9900 |
| 14:24428287:TGG:T | donor_gain | 0.9900 |
| 14:24428309:CCT:C | donor_gain | 0.9900 |
| 14:24428311:TTC:T | donor_gain | 0.9900 |
| 14:24430708:TTCCA:T | acceptor_loss | 0.9900 |
| 14:24430709:TCCAG:T | acceptor_loss | 0.9900 |
| 14:24430710:CCA:C | acceptor_loss | 0.9900 |
| 14:24430711:CAGGG:C | acceptor_loss | 0.9900 |
| 14:24430712:A:AG | acceptor_gain | 0.9900 |
| 14:24430712:A:T | acceptor_loss | 0.9900 |
| 14:24430712:AG:A | acceptor_gain | 0.9900 |
| 14:24430712:AGG:A | acceptor_gain | 0.9900 |
| 14:24430713:G:GG | acceptor_gain | 0.9900 |
| 14:24430713:GG:G | acceptor_gain | 0.9900 |
| 14:24430713:GGG:G | acceptor_gain | 0.9900 |
| 14:24430713:GGGCT:G | acceptor_gain | 0.9900 |
| 14:24430911:G:GT | donor_gain | 0.9900 |
| 14:24430912:A:T | donor_gain | 0.9900 |
AlphaMissense
1282 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:24428329:A:G | F126S | 1.000 |
| 14:24427811:C:T | G199D | 0.999 |
| 14:24427817:A:G | F197S | 0.999 |
| 14:24427970:T:A | N146I | 0.999 |
| 14:24428336:A:C | Y124D | 0.999 |
| 14:24428359:A:C | F116C | 0.999 |
| 14:24428359:A:G | F116S | 0.999 |
| 14:24428380:A:C | F109C | 0.999 |
| 14:24428761:G:C | F98L | 0.999 |
| 14:24428761:G:T | F98L | 0.999 |
| 14:24428762:A:C | F98C | 0.999 |
| 14:24428762:A:G | F98S | 0.999 |
| 14:24428763:A:G | F98L | 0.999 |
| 14:24428833:A:C | F74L | 0.999 |
| 14:24428833:A:T | F74L | 0.999 |
| 14:24428834:A:C | F74C | 0.999 |
| 14:24428834:A:G | F74S | 0.999 |
| 14:24428835:A:G | F74L | 0.999 |
| 14:24427816:G:C | F197L | 0.998 |
| 14:24427816:G:T | F197L | 0.998 |
| 14:24427817:A:C | F197C | 0.998 |
| 14:24427818:A:G | F197L | 0.998 |
| 14:24427831:C:A | W192C | 0.998 |
| 14:24427831:C:G | W192C | 0.998 |
| 14:24427889:A:C | L173W | 0.998 |
| 14:24427945:A:C | F154L | 0.998 |
| 14:24427945:A:T | F154L | 0.998 |
| 14:24427947:A:G | F154L | 0.998 |
| 14:24427979:A:G | L143P | 0.998 |
| 14:24428341:C:A | G122V | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000300505 (14:24428239 C>T), RS1000564660 (14:24426607 C>A,T), RS1003624867 (14:24428412 G>A,T), RS1003740892 (14:24428729 C>G,T), RS1004295122 (14:24427355 G>A), RS1004817321 (14:24427503 A>C,G), RS1005706606 (14:24428686 G>A), RS1006090366 (14:24430245 T>C), RS1006701909 (14:24430054 G>A), RS1007637874 (14:24429806 G>C), RS1007796611 (14:24430297 G>A), RS1007880557 (14:24427306 A>C), RS1008432422 (14:24426990 A>C,G), RS1009595876 (14:24428391 C>T), RS1010145549 (14:24426997 G>A,T)
Disease associations
OMIM: gene MIM:612978 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000759_4 | LDL cholesterol | 4.000000e-11 |
| GCST002898_9 | LDL cholesterol | 2.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004611 | low density lipoprotein cholesterol measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| afuresertib | increases expression | 1 |
| dicrotophos | increases expression | 1 |
| bisphenol A | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| abrine | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Estradiol | decreases expression | 1 |
| Folic Acid | decreases expression | 1 |
| Lead | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.